https://pipelinereview.com/oncorus-reports-initial-safety-tolerability-immune-activation-and-positive-clinical-response-data-from-its-ongoing-phase-1-clinical-study-of-oncr-177-its-lead-viral-immunotherapy-candidate-at-sitc-202/